The use of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer

This publication has 16 references indexed in Scilit:

• The potential to increase curative liver resection rates in metastatic colorectal cancer
  European Journal of Surgical Oncology, 2002
• Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases
  Annals of Surgical Oncology, 2001
• New treatments for advanced cancer: an approach to prioritization
  British Journal of Cancer, 2000
• Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
  Journal of Clinical Oncology, 2000
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
  Published by Elsevier ,2000
• Multicenter Phase II Study of Bimonthly High-Dose Leucovorin, Fluorouracil Infusion, and Oxaliplatin for Metastatic Colorectal Cancer Resistant to the Same Leucovorin and Fluorouracil Regimen
  Journal of Clinical Oncology, 1999
• Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
  Annals of Oncology, 1999
• Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen
  Annals of Oncology, 1998
• Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant Chemotherapy
  Annals of Surgery, 1996
• Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.
  BMJ, 1993